Cyrille Leperlier
Patrimonio netto: - $ in data 31/03/2024
Patrimonio netto: - $ in data 31/03/2024
Cyrille Raymond George Leperlier is currently an Independent Non-Executive Director at NuCana Plc since 2018.
Formerly, the role of Chief Executive Officer was held at Divlal SAS from 2020 to 2022.
The position of Medical Director was held at Rhone-Poulenc Rorer, Inc. Medical Director at Sanofi-Aventis Japan was held from 2014 to 2019.
Education includes graduate and doctorate degrees from the University of Paris Jussieu.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NUCANA PLC -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/03/2024 |
| Società | Posizione | Inizio |
|---|---|---|
| NUCANA PLC | Direttore/Membro del Consiglio | 01/05/2018 |
| Società | Posizione | Fine |
|---|---|---|
Divlal SAS | Amministratore Delegato | 01/11/2022 |
Sanofi-Aventis Japan | Direttore Tecnico/Scientifico/R&S | 01/12/2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Paris Jussieu
University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Japan | |
NuCana Plc
NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Divlal SAS |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale